login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
RENOVACOR INC (RCOR) Stock News
USA
- NYSEARCA:RCOR -
US75989E1064
-
Common Stock
3.2
USD
+0.15 (+4.92%)
Last: 11/30/2022, 8:04:02 PM
3.2
USD
0 (0%)
After Hours:
11/30/2022, 8:04:02 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
RCOR Latest News, Press Relases and Analysis
All
Press Releases
3 years ago - By: Kahn Swick & Foti, LLC
- Mentions:
RCKT
RENOVACOR INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Renovacor, Inc. - RCOR
3 years ago - By: InvestorPlace
- Mentions:
RUM
MULN
IPOF
Rumble (RUM) Stock Plunges on Second Trading Day
3 years ago - By: Benzinga
- Mentions:
RCKT
Rocket Pharmaceuticals Buys Renovacor, Strengthening Position In Gene Therapies For Heart Diseases
3 years ago - By: Kahn Swick & Foti, LLC
- Mentions:
RCKT
RENOVACOR INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Renovacor, Inc. - RCOR
3 years ago - By: Renovacor, Inc.
Renovacor Announces Upcoming Presentation at the 29th European Society of Gene & Cell Therapy Congress
3 years ago - By: Benzinga
- Mentions:
RCKT
Health Care Company Rocket Pharmaceuticals Announces Acquisition of Renovacor
3 years ago - By: Renovacor, Inc.
Renovacor Announces Upcoming Presentation at Keystone Symposia’s Heart Failure: Mechanisms and Therapies Conference
3 years ago - By: Ademi LLP
Shareholder Alert: Ademi LLP investigates whether Renovacor, Inc. has obtained a Fair Price in its transaction with Rocket Pharmaceuticals, Inc.
3 years ago - By: InvestorPlace
- Mentions:
MULN
IPOF
Fed Rate Hikes 2022: Investors, Mark Your Calendars for Sept. 21
3 years ago - By: InvestorPlace
- Mentions:
RCKT
VRAX
F
MGAM
Why Is Renovacor (RCOR) Stock Up 18% Today?
3 years ago - By: Halper Sadeh LLC
RCOR STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of Renovacor, Inc. Is Fair to Shareholders
3 years ago - By: Rocket Pharmaceuticals, Inc. and Renovacor, Inc.
- Mentions:
RCKT
Rocket Pharmaceuticals to Acquire Renovacor, Extending Leadership in AAV-based Cardiac Gene Therapy
Please enable JavaScript to continue using this application.